Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life

The introduction of highly active antiretroviral therapy during the 1990s was crucial to the decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (AIDS) and turned human immunodeficiency virus (HIV) infection into a chronic condition. Consequently, the HIV/AIDS population is becoming older. The aim of this study was to describe the immunological, clinical and comorbidity profile of an urban cohort of patients with HIV/AIDS followed up at Instituto de Pesquisa Clinica Evandro Chagas, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Retrospective data from 2307 patients during January 1st, 2008 and December 31st, 2008 were collected. For continuous variables, Cuzick's non-parametric test was used. For categorical variables, the Cochran-Armitage non-parametric test for tendency was used. For all tests, the threshold for statistical significance was set at 5%. In 2008, 1023 (44.3%), 823 (35.7%), 352 (15.3%) and 109 (4.7%) were aged 18-39, 40-49, 50-59 and >60 years-old, respectively. Older and elderly patients (>40 years) were more likely to have viral suppression than younger patients (18-39 years) (p 0.001). No significant difference in the latest CD4+ T lymphocyte count in the different age strata was observed, although elderly patients (> 50 years) had lower CD4+ T lymphocyte nadir (p 0.02). The number of comorbidities increased with age and the same pattern was observed for the majority of the comorbidities, including diabetes mellitus, dyslipidemia, hypertension, cardiovascular diseases, erectile dysfunction, HCV, renal dysfunction and also for non-AIDSrelated cancers (p 0.001). With the survival increase associated to successful antiretroviral therapy and with the increasing new infections among elderly group, the burden associated to the diagnosis and treatment of the non-AIDS related HIV comorbidities will grow. Longitudinal studies on the impact of aging on the HIV/AIDS population are still necessary, especially in resource-limited countries.

Saved in:
Bibliographic Details
Main Authors: Torres,Thiago Silva, Cardoso,Sandra Wagner, Velasque,Luciane de Souza, Marins,Luana Monteiro Spindola, Oliveira,Marília Santini de, Veloso,Valdilea Gonçalves, Grinsztejn,Beatriz
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000300004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702013000300004
record_format ojs
spelling oai:scielo:S1413-867020130003000042013-06-13Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of lifeTorres,Thiago SilvaCardoso,Sandra WagnerVelasque,Luciane de SouzaMarins,Luana Monteiro SpindolaOliveira,Marília Santini deVeloso,Valdilea GonçalvesGrinsztejn,Beatriz HIV AIDS Aging Elderly Brazil Comorbidity HAART The introduction of highly active antiretroviral therapy during the 1990s was crucial to the decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (AIDS) and turned human immunodeficiency virus (HIV) infection into a chronic condition. Consequently, the HIV/AIDS population is becoming older. The aim of this study was to describe the immunological, clinical and comorbidity profile of an urban cohort of patients with HIV/AIDS followed up at Instituto de Pesquisa Clinica Evandro Chagas, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Retrospective data from 2307 patients during January 1st, 2008 and December 31st, 2008 were collected. For continuous variables, Cuzick's non-parametric test was used. For categorical variables, the Cochran-Armitage non-parametric test for tendency was used. For all tests, the threshold for statistical significance was set at 5%. In 2008, 1023 (44.3%), 823 (35.7%), 352 (15.3%) and 109 (4.7%) were aged 18-39, 40-49, 50-59 and >60 years-old, respectively. Older and elderly patients (>40 years) were more likely to have viral suppression than younger patients (18-39 years) (p 0.001). No significant difference in the latest CD4+ T lymphocyte count in the different age strata was observed, although elderly patients (> 50 years) had lower CD4+ T lymphocyte nadir (p 0.02). The number of comorbidities increased with age and the same pattern was observed for the majority of the comorbidities, including diabetes mellitus, dyslipidemia, hypertension, cardiovascular diseases, erectile dysfunction, HCV, renal dysfunction and also for non-AIDSrelated cancers (p 0.001). With the survival increase associated to successful antiretroviral therapy and with the increasing new infections among elderly group, the burden associated to the diagnosis and treatment of the non-AIDS related HIV comorbidities will grow. Longitudinal studies on the impact of aging on the HIV/AIDS population are still necessary, especially in resource-limited countries.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.17 n.3 20132013-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000300004en10.1016/j.bjid.2012.10.024
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Torres,Thiago Silva
Cardoso,Sandra Wagner
Velasque,Luciane de Souza
Marins,Luana Monteiro Spindola
Oliveira,Marília Santini de
Veloso,Valdilea Gonçalves
Grinsztejn,Beatriz
spellingShingle Torres,Thiago Silva
Cardoso,Sandra Wagner
Velasque,Luciane de Souza
Marins,Luana Monteiro Spindola
Oliveira,Marília Santini de
Veloso,Valdilea Gonçalves
Grinsztejn,Beatriz
Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
author_facet Torres,Thiago Silva
Cardoso,Sandra Wagner
Velasque,Luciane de Souza
Marins,Luana Monteiro Spindola
Oliveira,Marília Santini de
Veloso,Valdilea Gonçalves
Grinsztejn,Beatriz
author_sort Torres,Thiago Silva
title Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
title_short Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
title_full Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
title_fullStr Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
title_full_unstemmed Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
title_sort aging with hiv: an overview of an urban cohort in rio de janeiro (brazil) across decades of life
description The introduction of highly active antiretroviral therapy during the 1990s was crucial to the decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (AIDS) and turned human immunodeficiency virus (HIV) infection into a chronic condition. Consequently, the HIV/AIDS population is becoming older. The aim of this study was to describe the immunological, clinical and comorbidity profile of an urban cohort of patients with HIV/AIDS followed up at Instituto de Pesquisa Clinica Evandro Chagas, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Retrospective data from 2307 patients during January 1st, 2008 and December 31st, 2008 were collected. For continuous variables, Cuzick's non-parametric test was used. For categorical variables, the Cochran-Armitage non-parametric test for tendency was used. For all tests, the threshold for statistical significance was set at 5%. In 2008, 1023 (44.3%), 823 (35.7%), 352 (15.3%) and 109 (4.7%) were aged 18-39, 40-49, 50-59 and >60 years-old, respectively. Older and elderly patients (>40 years) were more likely to have viral suppression than younger patients (18-39 years) (p 0.001). No significant difference in the latest CD4+ T lymphocyte count in the different age strata was observed, although elderly patients (> 50 years) had lower CD4+ T lymphocyte nadir (p 0.02). The number of comorbidities increased with age and the same pattern was observed for the majority of the comorbidities, including diabetes mellitus, dyslipidemia, hypertension, cardiovascular diseases, erectile dysfunction, HCV, renal dysfunction and also for non-AIDSrelated cancers (p 0.001). With the survival increase associated to successful antiretroviral therapy and with the increasing new infections among elderly group, the burden associated to the diagnosis and treatment of the non-AIDS related HIV comorbidities will grow. Longitudinal studies on the impact of aging on the HIV/AIDS population are still necessary, especially in resource-limited countries.
publisher Brazilian Society of Infectious Diseases
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000300004
work_keys_str_mv AT torresthiagosilva agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
AT cardososandrawagner agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
AT velasquelucianedesouza agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
AT marinsluanamonteirospindola agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
AT oliveiramariliasantinide agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
AT velosovaldileagoncalves agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
AT grinsztejnbeatriz agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife
_version_ 1756416467442597888